Sarah Cannon Research Institute at Tennessee Oncology - Chattanooga — Chattanooga, Tennessee

Sarah Cannon Research Institute at Tennessee Oncology - Chattanooga is a clinical research site located in Chattanooga, Tennessee, United States 37404.

Crixeo Clinical Trials Trust Score: 11/100 (FAILING). This profile has not yet been claimed by the site owner.

Sarah Cannon Research Institute at Tennessee Oncology - Chattanooga has participated in 2 clinical trials with 1 currently active.

Therapeutic areas: Non-small Cell Lung Cancer, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor.

Sponsors: Daiichi Sankyo.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Chattanooga

Browse all research sites in Tennessee · View every site in Chattanooga

• University of Tennessee/Erlanger Oncology and Hematology
• University of Tennessee Erlanger Cardiology
• University Oncology/ Hematology Associates
• Center for Sports Medicine and Orthopaedics; Memorial Hospital
• Children's Hospital at Erlanger
• University of Tennessee-Chattanooga Unit
• University Oncology and Hematology Associates
• Memorial Hospital
• University of Diabetes and Endocrine Consultants
• University Diabetes & Endocrine Consultants /ID# 170392
• University of Tennessee Erlanger Oncology & Hematology
• Parkridge East Hospital

Sponsor Feasibility Report

Trust Score: 11/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Sarah Cannon Research Institute at Tennessee Oncology - Chattanooga?

Sarah Cannon Research Institute at Tennessee Oncology - Chattanooga has a Crixeo Trust Score of 11/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Sarah Cannon Research Institute at Tennessee Oncology - Chattanooga conducted?

Sarah Cannon Research Institute at Tennessee Oncology - Chattanooga has 2 clinical trials on record, with 1 currently active. Their work covers Non-small Cell Lung Cancer, Non-Small Cell Lung Cancer Metastatic, Non-Small Cell Lung Cancer With Mutation in Epidermal Growth Factor Receptor.

Is Sarah Cannon Research Institute at Tennessee Oncology - Chattanooga accredited by Crixeo Clinical Trials?

Sarah Cannon Research Institute at Tennessee Oncology - Chattanooga has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Sarah Cannon Research Institute at Tennessee Oncology - Chattanooga?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.